Non-linear association between long-term air pollution exposure and risk of metabolic dysfunction-associated steatotic liver disease

被引:3
|
作者
Cheng, Wei -Chun [1 ,2 ,3 ]
Wong, Pei-Yi [4 ]
Wu, Chih-Da [5 ,6 ,7 ]
Cheng, Pin -Nan [2 ]
Lee, Pei -Chen [1 ]
Li, Chung-Yi [1 ,8 ,9 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Dept Internal Med, Coll Med, Tainan, Taiwan
[3] Minist Hlth & Welf, Tainan Hosp, Dept Gastroenterol & Hepatol, Tainan, Taiwan
[4] Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Tainan, Taiwan
[5] Natl Cheng Kung Univ, Dept Geomat, Tainan, Taiwan
[6] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan
[7] Natl Chung Hsing Univ, Innovat & Dev Ctr Sustainable Agr, Taichung, Taiwan
[8] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
[9] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan
关键词
Metabolic dysfunction-associated steatotic liver disease (MASLD); Air pollutants; Particular matters; Risk factors; Epidemiologic study; Restricted cubic spline (RCS); AMERICAN-COLLEGE; MANAGEMENT; MORTALITY; HEALTH; GUIDELINES; DIAGNOSIS;
D O I
10.1265/ehpm.23-00271
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Metabolic Dysfunction -associated Steatotic Liver Disease (MASLD) has become a global epidemic, and air pollution has been identified as a potential risk factor. This study aims to investigate the non-linear relationship between ambient air pollution and MASLD prevalence. Method: In this cross-sectional study, participants undergoing health checkups were assessed for three-year average air pollution exposure. MASLD diagnosis required hepatic steatosis with at least 1 out of 5 cardiometabolic criteria. A stepwise approach combining data visualization and regression modeling was used to determine the most appropriate link function between each of the six air pollutants and MASLD. A covariate-adjusted six -pollutant model was constructed accordingly. Results: A total of 131,592 participants were included, with 40.6% met the criteria of MASLD. "Threshold link function," "interaction link function," and "restricted cubic spline (RCS) link functions" best -fitted associations between MASLD and PM2.5, PM10/CO, and O3 /SO2/NO2, respectively. In the six -pollutant model, significant positive associations were observed when pollutant concentrations were over: 34.64 mu g/m3 for PM2.5, 57.93 mu g/m3 for PM10, 56 mu g/m3 for O3, below 643.6 mu g/m3 for CO, and within 33 and 48 mu g/m3 for NO2. The six -pollutant model using these best -fitted link functions demonstrated superior model fitting compared to exposurecategorized model or linear link function model assuming proportionality of odds. Conclusion: Non-linear associations were found between air pollutants and MASLD prevalence. PM2.5, PM10, O3, CO, and NO2 exhibited positive associations with MASLD in specific concentration ranges, highlighting the need to consider non-linear relationships in assessing the impact of air pollution on MASLD.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Nutrients associated with metabolic dysfunction-associated steatotic liver disease
    Jeong, Seogsong
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e81 - e82
  • [32] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [33] Hepatocellular carcinoma incidence and risk stratification in patients with metabolic dysfunction-associated steatotic liver disease on long-term follow-up
    Caviglia, G. P.
    Pelusi, S.
    Liguori, A.
    Guariglia, M.
    Rosso, C.
    Armandi, A.
    Gjini, K.
    Viceconti, N.
    Abate, M. L.
    Miele, L.
    Valenti, L.
    Bugianesi, E.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S12 - S12
  • [34] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34
  • [35] Non-invasive testing in metabolic dysfunction-associated steatotic liver disease
    Dawod, Sanad
    Brown, Kimberly
    FRONTIERS IN MEDICINE, 2024, 11
  • [36] Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction-associated steatotic liver disease
    Wang, Roy X.
    Lee, Jason J.
    Mirda, Danielle
    Hao, Jinxuan
    Goebel, Anna M.
    Deutsch-Link, Sasha
    Serper, Marina
    Bittermann, Therese
    LIVER TRANSPLANTATION, 2024, 30 (12)
  • [37] Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
    Ionescu, Vlad Alexandru
    Gheorghe, Gina
    Bacalbasa, Nicolae
    Diaconu, Camelia Cristina
    BIOMOLECULES, 2025, 15 (02)
  • [38] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
    Zheng, Haixiang
    Sechi, Leonardo Antonio
    Navarese, Eliano Pio
    Casu, Gavino
    Vidili, Gianpaolo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [39] Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes
    Wang, Qian
    Chen, Huiyi
    Deng, Huiling
    Zhang, Minyi
    Hu, Haoyue
    Ouyang, Haotong
    Ma, Lien
    Liu, Ruiyan
    Sun, Jian
    Hu, Guifang
    Wang, Kaifeng
    DIABETES & METABOLISM, 2025, 51 (03)
  • [40] Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study
    Peng, Yu
    Wang, Peng
    Liu, Fubin
    Wang, Xixuan
    Si, Changyu
    Gong, Jianxiao
    Zhou, Huijun
    Gu, Jiale
    Qin, Ailing
    Song, Weijie
    Song, Fangfang
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1940 - 1949